This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cannon, P M Articles by Kingsman, A J Search for Related Content PubMed PubMed Citation Articles by Cannon, P M Articles by Kingsman, A J

 Previous Article  |  Next Article 

J Virol. 1994 August; 68(8): 4768-4775

Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

Department of Biochemistry, University of Oxford, United Kingdom.

ABSTRACT

Sequence comparisons of the integrase (IN) proteins from different retroviruses have identified several highly conserved residues. We have introduced mutations at 16 of these sites into the integrase gene of human immunodeficiency virus type 1 and analyzed the phenotypes of the resulting viruses. The viruses were all normal for p24 content and reverse transcriptase activity. In addition, all of the mutants could infect T-cell lines and undergo reverse transcription, as assessed by PCR analysis. Most of the mutant viruses also had normal Western blot (immunoblot) profiles, although three of the mutations resulted in reduced signals for IN relative to the wild type on the immunoblots and mutation of residue W235 completely abolished recognition of the protein by pooled sera from human immunodeficiency virus type 1-positive patients. Mutations that have previously been shown to abolish activity in in vitro studies produced noninfectious viruses. The substitution of W235 was notable in producing a noninfectious virus, despite previous reports of this residue being nonessential for IN activity in vitro (A.D. Leavitt, L. Shiue, and H.E. Varmus, J. Biol. Chem. 268:2113-2119, 1993). In addition, we have identified four highly conserved residues that can be mutated without any affect on viral replication in T-cell lines.

This article has been cited by other articles:

• Oh, J., Chang, K. W., Wierzchoslawski, R., Alvord, W. G., Hughes, S. H. (2008). Rous Sarcoma Virus (RSV) Integration In Vivo: a CA Dinucleotide Is Not Required in U3, and RSV Linear DNA Does Not Autointegrate. J. Virol. 82: 503-512 [Abstract] [Full Text]  
• Cara, A., Klotman, M. E. (2006). Retroviral E-DNA: persistence and gene expression in nondividing immune cells. J. Leukoc. Biol. 80: 1013-1017 [Abstract] [Full Text]  
• Lee, D. J., Robinson, W. E. Jr. (2006). Preliminary Mapping of a Putative Inhibitor-Binding Pocket for Human Immunodeficiency Virus Type 1 Integrase Inhibitors. Antimicrob. Agents Chemother. 50: 134-142 [Abstract] [Full Text]  
• Li, M., Craigie, R. (2005). Processing of Viral DNA Ends Channels the HIV-1 Integration Reaction to Concerted Integration. J. Biol. Chem. 280: 29334-29339 [Abstract] [Full Text]  
• Lee, M. C., Deng, J., Briggs, J. M., Duan, Y. (2005). Large-Scale Conformational Dynamics of the HIV-1 Integrase Core Domain and Its Catalytic Loop Mutants. Biophys. J 88: 3133-3146 [Abstract] [Full Text]  
• Lu, R., Limon, A., Ghory, H. Z., Engelman, A. (2005). Genetic Analyses of DNA-Binding Mutants in the Catalytic Core Domain of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 79: 2493-2505 [Abstract] [Full Text]  
• Ikeda, T., Nishitsuji, H., Zhou, X., Nara, N., Ohashi, T., Kannagi, M., Masuda, T. (2004). Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA during Acute Infection. J. Virol. 78: 11563-11573 [Abstract] [Full Text]  
• Lee, D. J., Robinson, W. E. Jr. (2004). Human Immunodeficiency Virus Type 1 (HIV-1) Integrase: Resistance to Diketo Acid Integrase Inhibitors Impairs HIV-1 Replication and Integration and Confers Cross-Resistance to L-Chicoric Acid. J. Virol. 78: 5835-5847 [Abstract] [Full Text]  
• Zhu, K., Dobard, C., Chow, S. A. (2004). Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase. J. Virol. 78: 5045-5055 [Abstract] [Full Text]  
• Bischerour, J., Leh, H., Deprez, E., Brochon, J.-C., Mouscadet, J.-F. (2002). Disulfide-Linked Integrase Oligomers Involving C280 Residues Are Formed In Vitro and In Vivo but Are Not Essential for Human Immunodeficiency Virus Replication. J. Virol. 77: 135-141 [Abstract] [Full Text]  
• Aye, M., Dildine, S. L., Claypool, J. A., Jourdain, S., Sandmeyer, S. B. (2001). A Truncation Mutant of the 95-Kilodalton Subunit of Transcription Factor IIIC Reveals Asymmetry in Ty3 Integration. Mol. Cell. Biol. 21: 7839-7851 [Abstract] [Full Text]  
• Fang, J.-Y., Mikovits, J. A., Bagni, R., Petrow-Sadowski, C. L., Ruscetti, F. W. (2001). Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation. J. Virol. 75: 9753-9761 [Abstract] [Full Text]  
• Nakajima, N., Lu, R., Engelman, A. (2001). Human Immunodeficiency Virus Type 1 Replication in the Absence of Integrase-Mediated DNA Recombination: Definition of Permissive and Nonpermissive T-Cell Lines. J. Virol. 75: 7944-7955 [Abstract] [Full Text]  
• Tsurutani, N., Kubo, M., Maeda, Y., Ohashi, T., Yamamoto, N., Kannagi, M., Masuda, T. (2000). Identification of Critical Amino Acid Residues in Human Immunodeficiency Virus Type 1 IN Required for Efficient Proviral DNA Formation at Steps prior to Integration in Dividing and Nondividing Cells. J. Virol. 74: 4795-4806 [Abstract] [Full Text]  
• Goodarzi, G., Pursley, M., Felock, P., Witmer, M., Hazuda, D., Brackmann, K., Grandgenett, D. (1999). Efficiency and Fidelity of Full-Site Integration Reactions Using Recombinant Simian Immunodeficiency Virus Integrase. J. Virol. 73: 8104-8111 [Abstract] [Full Text]  
• Ishikawa, T., Okui, N., Kobayashi, N., Sakuma, R., Kitamura, T., Kitamura, Y. (1999). Monoclonal Antibodies against the Minimal DNA-Binding Domain in the Carboxyl-Terminal Region of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 73: 4475-4480 [Abstract] [Full Text]  
• Nymark-McMahon, M. H., Sandmeyer, S. B. (1999). Mutations in Nonconserved Domains of Ty3 Integrase Affect Multiple Stages of the Ty3 Life Cycle. J. Virol. 73: 453-465 [Abstract] [Full Text]  
• Masuda, T., Kuroda, M. J., Harada, S. (1998). Specific and Independent Recognition of U3 and U5 att Sites by Human Immunodeficiency Virus Type 1 Integrase In Vivo. J. Virol. 72: 8396-8402 [Abstract] [Full Text]  
• Dildine, S. L., Respess, J., Jolly, D., Sandmeyer, S. B. (1998). A Chimeric Ty3/Moloney Murine Leukemia Virus Integrase Protein Is Active In Vivo. J. Virol. 72: 4297-4307 [Abstract] [Full Text]  
• Acel, A., Udashkin, B. E., Wainberg, M. A., Faust, E. A. (1998). Efficient Gap Repair Catalyzed In Vitro by an Intrinsic DNA Polymerase Activity of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 72: 2062-2071 [Abstract] [Full Text]  
• Scottoline, B P, Chow, S, Ellison, V, Brown, P O (1997). Disruption of the terminal base pairs of retroviral DNA during integration.. Genes Dev. 11: 371-382 [Abstract]  
• Kirchner, J, Connolly, C., Sandmeyer, S. (1995). Requirement of RNA polymerase III transcription factors for in vitro position-specific integration of a retroviruslike element. Science 267: 1488-1491 [Abstract]